Sign In
Buy MRNA
$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026
02:45am, Wednesday, 03'rd Jun 2026
This biotech is making solid progress with several pipeline candidates. It could have a stronger lineup of approved products within a few years.
Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”
04:34pm, Tuesday, 02'nd Jun 2026
eCommerce Powered by FFF Enterprises™ delivers an enhanced ordering experience for Moderna customers. eCommerce Powered by FFF Enterprises™ delivers an enhanced ordering experience for Moderna cus
MRNA Partners With CEPI to Develop Vaccine for Bundibugyo Ebolavirus
12:01pm, Tuesday, 02'nd Jun 2026
Moderna gains up to $50M from CEPI to advance a Bundibugyo ebolavirus vaccine as the partnership expands amid an ongoing Ebola outbreak.
Moderna to Present at Upcoming Conference in June 2026
07:00am, Tuesday, 02'nd Jun 2026
CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference: Goldman Sachs 47th Annual Global Healthca
Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data Transcript
01:04am, Tuesday, 02'nd Jun 2026
Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data Transcript
Moderna Reports Strong 5-Year Cancer Vaccine Data, Expands CEPI Partnership; Stock Falls
12:39pm, Monday, 01'st Jun 2026
Moderna, Inc. (NASDAQ:MRNA) stock is trading lower on Monday.
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of recurr
Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine
05:37am, Monday, 01'st Jun 2026
Moderna said on Monday it has partnered with the Coalition for Epidemic Preparedness Innovations to develop a potential vaccine against Bundibugyo ebolavirus, the strain linked to the ongoing �
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
05:00am, Monday, 01'st Jun 2026
Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation CAMBRIDGE, MA / ACCESS Newswir
Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
03:54am, Saturday, 30'th May 2026
Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Moderna, Merck cancer combo cuts melanoma spread risk at five years
05:03pm, Thursday, 21'st May 2026
Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body by 59% after five years of follow-up, data from a mid-stage trial showe
US FDA to hold expert committee meeting to review Moderna's flu vaccine
11:26am, Thursday, 21'st May 2026
The U.S. FDA said on Thursday it would hold a meeting of outside experts next month to review Moderna's experimental flu shot.
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now
09:36am, Thursday, 21'st May 2026
Moderna (NASDAQ:MRNA | MRNA Price Prediction) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement.
Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
12:20pm, Tuesday, 19'th May 2026
Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
01:15pm, Wednesday, 13'th May 2026
The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking the potential winners in the hantavirus vaccine market would hardly be worth the time and risk.
